• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Fluorobenzenes

Professional Introduction to 4-(2,5-difluorophenyl)butanoic acid (CAS No. 899350-25-5)

4-(2,5-difluorophenyl)butanoic acid, identified by the Chemical Abstracts Service number 899350-25-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound belongs to the class of fluorinated aromatic carboxylic acids, a subset known for its versatile applications in medicinal chemistry. The presence of fluorine atoms at the 2 and 5 positions of the phenyl ring introduces unique electronic and steric properties, making this molecule a valuable scaffold for drug discovery and development.

The structural motif of 4-(2,5-difluorophenyl)butanoic acid consists of a butanoic acid backbone attached to a 2,5-difluorophenyl group. This configuration imparts specific interactions with biological targets, which has been leveraged in the design of novel therapeutic agents. The fluorine atoms enhance lipophilicity and metabolic stability, key factors in optimizing pharmacokinetic profiles. Recent studies have highlighted the potential of fluorinated carboxylic acids in modulating enzyme activity and receptor binding, areas where 4-(2,5-difluorophenyl)butanoic acid has shown promise.

In the realm of drug discovery, the synthesis and characterization of 4-(2,5-difluorophenyl)butanoic acid have been instrumental in developing compounds with enhanced binding affinity and selectivity. For instance, derivatives of this scaffold have been explored as inhibitors of various kinases and proteases. The fluorine substitution pattern influences both the shape and electronic distribution of the molecule, allowing for precise tuning of its interaction with biological targets. This has led to several preclinical candidates entering pipelines for treating inflammatory diseases and cancer.

Recent advancements in computational chemistry have further illuminated the potential of 4-(2,5-difluorophenyl)butanoic acid as a pharmacophore. Molecular docking studies suggest that its structure can be optimized to interact with pockets on proteins involved in metabolic pathways. The carboxylic acid moiety serves as a hydrogen bond acceptor, while the phenyl ring provides hydrophobic interactions. These features make it an attractive candidate for designing small-molecule modulators.

The synthetic route to 4-(2,5-difluorophenyl)butanoic acid involves multi-step organic transformations, including fluorination and carboxylation reactions. The introduction of fluorine atoms at specific positions requires careful control to avoid unwanted side products. Techniques such as palladium-catalyzed cross-coupling and electrochemical fluorination have been employed to achieve high regioselectivity. These synthetic methodologies are critical for producing sufficient quantities of the compound for both research and potential industrial applications.

From a biochemical perspective, 4-(2,5-difluorophenyl)butanoic acid has been investigated for its effects on cellular pathways relevant to neurodegenerative disorders. Preliminary data indicate that it may modulate neurotransmitter release by interacting with specific receptors or enzymes. The fluorinated aromatic ring enhances penetration through the blood-brain barrier, a crucial factor for central nervous system (CNS) drug development. This property has sparked interest in exploring its role as an intermediate in synthesizing next-generation therapeutics.

The role of fluorine in medicinal chemistry extends beyond mere structural modification; it significantly impacts the pharmacological properties of compounds like 4-(2,5-difluorophenyl)butanoic acid. Fluorine atoms can alter metabolic half-life, enhance binding affinity, and improve resistance to enzymatic degradation. These effects are particularly relevant in designing drugs with prolonged efficacy and reduced dosing frequency. The growing body of literature on fluorinated compounds underscores their importance in modern drug design.

In conclusion,4-(2,5-difluorophenyl)butanoic acid (CAS No. 899350-25-5) represents a compelling example of how structural modifications can yield compounds with significant therapeutic potential. Its unique combination of electronic and steric properties makes it a versatile scaffold for further derivatization and optimization. As research continues to uncover new applications for fluorinated carboxylic acids,4-(2,5-difluorophenyl)butanoic acid is poised to play a pivotal role in the development of innovative pharmaceuticals.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)